$18.5 million awarded to expand U.S.-based manufacturing of raw materials for essential medicines

URLhttps://www.bullrunnow.com/news/article/18.5_milli
SourceBull Run Now
Date Published07/19/2024

Additional Reshoring Information:

Company/Division name Capra Biosciences
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2024
Domestically, the work will be done:In-house
Capital investment ($):7.5
State(s) reshored to:VA
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredactive pharmaceutical ingredients
What domestic positive factors made reshoring more attractive?Government Incentives
Find Reshoring Articles